Product Information
METOPROLOL TARTRATE 100 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0287 per EA under NDC 00378004710. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jan 16, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378004710
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METOPROLOL TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA076704FDA Approved
1/16/2004
TE Code
AB
On Market Since
12/23/1993
Pharmacological Classes
Price Statistics
The NADAC for METOPROLOL TARTRATE 100 MG TAB has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 19.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0287 per EA |
|---|---|
| All-time high | $0.0440 (Aug 10, 2016) |
| All-time low | $0.0213 (Nov 20, 2024) |
| 52-week high | $0.0291 |
| 52-week low | $0.0254 |
| Median price | $0.0322 |
| Average price | $0.0324 |
| Largest weekly change | -27.2% (Nov 20, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
metoprolol tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOPROLOL TARTRATE 100 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL TARTRATE 100 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $0.0287 per EA (NDC 00378004710), effective Sep 30, 2026.
How has the price of METOPROLOL TARTRATE 100 MG TAB changed over time?
Over the history we have for it, the NADAC for METOPROLOL TARTRATE 100 MG TAB has declined 19.4%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for METOPROLOL TARTRATE 100 MG TAB?
Since Nov 28, 2013, the NADAC for METOPROLOL TARTRATE 100 MG TAB has ranged from a low of $0.0213 (Nov 20, 2024) to a high of $0.0440 (Aug 10, 2016), with a median of $0.0322 per EA.
Are there cheaper alternatives to METOPROLOL TARTRATE 100 MG TAB?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METOPROLOL TARTRATE 100 MG TAB, is $0.0275 per EA — about 4% below METOPROLOL TARTRATE 100 MG TAB.
Who manufactures METOPROLOL TARTRATE 100 MG TAB?
METOPROLOL TARTRATE 100 MG TAB (NDC 00378004710) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.